Homocysteine levels, genetic background, and cognitive impairment in Parkinson’s disease

BACKGROUND: Hyperhomocysteinemia is considered an independent risk factor for cognitive impairment. OBJECTIVE: To study the correlation between homocysteine levels and cognitive impairment in patients with PD. METHODS: We conducted a case–control study that included 246 patients with PD, of whom 32...

Descripción completa

Detalles Bibliográficos
Autores principales: Periñán, María Teresa, Macías-García, Daniel, Jesús, Silvia, Martín-Rodríguez, Juan Francisco, Muñoz-Delgado, Laura, Jimenez-Jaraba, Maria Valle, Buiza-Rueda, Dolores, Bonilla-Toribio, Marta, Adarmes-Gómez, Astrid Daniela, Gómez-Garre, Pilar, Mir, Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813118/
https://www.ncbi.nlm.nih.gov/pubmed/36169739
http://dx.doi.org/10.1007/s00415-022-11361-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813118/
https://www.ncbi.nlm.nih.gov/pubmed/36169739
http://dx.doi.org/10.1007/s00415-022-11361-y

Ejemplares similares